PATENT CLAIM ANALYSIS

Application Number: 16090728
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "017200"]

Abstract:
Neuropeptide S receptor agonists are provided. The NPS agonists include trimeric, tetrameric, pentameric or hexameric peptidomimetic analogs exhibiting affinity for and activity at the neuropeptide S receptor. The peptidomimetic molecules may be useful in the treatment of disorders, syndromes and conditions mediated by modulation of the neuropeptide S receptor such as substance abuse, narcolepsy, insomnia, obesity, cognitive decline, dementia, Alzheimer's disease, panic disorder, generalized anxiety, PTSD, phobias, schizophrenia and as supportive medication during any kind of cessation program in cognitive behavioral therapy, such as drug addiction, eating disorders and gambling.

Claim (Index 20):
The method of  claim 18 , wherein the condition or disorder where modulation of neuropeptide S receptor activity is of therapeutic benefit is selected from the group consisting of substance abuse, narcolepsy, insomnia, obesity, cognitive decline, dementia, Alzheimer's disease, panic disorder, generalized anxiety, PTSD, phobias, and schizophrenia.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15229942', '13160086', '13483926', '10846482', '11721910']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8109430302300985
- 35 USC 102 Novelty (BERT): 0.5094109164864551
- Combined Prediction Score: 0.7807898188557342
- Mean Citation Score: 274.275638
- Max Citation Score: 282.69418
- Similarity Product: 195.2499938357293

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test